Auro Laboratories [AUROLAB] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison
Auro Laboratories
BSE
Loading...
Gujarat Themis
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Auro Laboratories wins in 5 metrics, Gujarat Themis wins in 13 metrics, with 0 ties. Gujarat Themis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Auro Laboratories | Gujarat Themis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 145.29 | 103.15 | Gujarat Themis |
| Price-to-Book Ratio | 3.32 | 18.55 | Auro Laboratories |
| Debt-to-Equity Ratio | 104.76 | 12.27 | Gujarat Themis |
| PEG Ratio | -1.27 | -3.26 | Gujarat Themis |
| EV/EBITDA | 88.13 | 71.94 | Gujarat Themis |
| Profit Margin (TTM) | 5.96% | 30.17% | Gujarat Themis |
| Operating Margin (TTM) | -8.69% | 33.14% | Gujarat Themis |
| EBITDA Margin (TTM) | N/A | 33.14% | N/A |
| Return on Equity | 4.28% | 19.64% | Gujarat Themis |
| Return on Assets (TTM) | 1.86% | 16.19% | Gujarat Themis |
| Free Cash Flow (TTM) | $-180.54M | $-251.22M | Auro Laboratories |
| Dividend Yield | N/A | 0.17% | N/A |
| 1-Year Return | 2.63% | 95.83% | Gujarat Themis |
| Price-to-Sales Ratio (TTM) | 8.64 | 31.17 | Auro Laboratories |
| Enterprise Value | $1.86B | $46.35B | Gujarat Themis |
| EV/Revenue Ratio | 11.30 | 31.35 | Auro Laboratories |
| Gross Profit Margin (TTM) | 67.54% | 77.71% | Gujarat Themis |
| Revenue per Share (TTM) | $26 | $14 | Auro Laboratories |
| Earnings per Share (Diluted) | $1.57 | $4.10 | Gujarat Themis |
| Beta (Stock Volatility) | 0.20 | -0.37 | Gujarat Themis |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Auro Laboratories vs Gujarat Themis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Auro Laboratories | -3.33% | -7.33% | -4.38% | -13.53% | -10.49% | -16.18% |
| Gujarat Themis | 1.37% | 5.81% | 11.73% | 24.24% | 72.58% | 76.09% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Auro Laboratories | 2.63% | 189.75% | 185.44% | 1,208.61% | 4,390.84% | 3,637.29% |
| Gujarat Themis | 95.83% | 95.83% | 95.83% | 95.83% | 95.83% | 95.83% |
News Based Sentiment: Auro Laboratories vs Gujarat Themis
Auro Laboratories
News based Sentiment: NEGATIVE
September proved to be a difficult month for Auro Laboratories, with a significant drop in share price and continued revenue declines overshadowing the long-term optimistic projections. The company's financial struggles are evident, making it a high-risk investment, and the upcoming trading window closure suggests potential significant developments are on the horizon.
Gujarat Themis
News based Sentiment: MIXED
October 2025 was a mixed month for Gujarat Themis Biosyn Ltd., with declining financial results countered by positive stock movement and investor sentiment. While the revenue and profit decreases are concerning, the market's reaction and analyst targets suggest potential for recovery, making it a cautiously optimistic outlook.
Performance & Financial Health Analysis: Auro Laboratories vs Gujarat Themis
| Metric | AUROLAB | GUJTHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.50B | ₹46.19B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 4,177 | 353,996 |
| 90 Day Avg. Volume | 6,853 | 202,276 |
| Last Close | ₹220.50 | ₹428.70 |
| 52 Week Range | ₹170.00 - ₹303.00 | ₹208.00 - ₹434.25 |
| % from 52W High | -27.23% | -1.28% |
| All-Time High | ₹307.20 (May 06, 2024) | ₹434.25 (Oct 06, 2025) |
| % from All-Time High | -28.22% | -1.28% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.52% | -0.08% |
| Quarterly Earnings Growth | -0.52% | -0.32% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.30% |
| Operating Margin (TTM) | -0.09% | 0.33% |
| Return on Equity (TTM) | 0.04% | 0.20% |
| Debt to Equity (MRQ) | 104.76 | 12.27 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹68.67 | ₹22.80 |
| Cash per Share (MRQ) | ₹1.02 | ₹1.15 |
| Operating Cash Flow (TTM) | ₹74.16M | ₹970.68M |
| Levered Free Cash Flow (TTM) | ₹18.39M | ₹487.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.17% |
| Last 12-Month Dividend | N/A | ₹0.67 |
Valuation & Enterprise Metrics Analysis: Auro Laboratories vs Gujarat Themis
| Metric | AUROLAB | GUJTHEM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 145.29 | 103.15 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -1.27 | -3.26 |
| Price to Sales (TTM) | 8.64 | 31.17 |
| Price to Book (MRQ) | 3.32 | 18.55 |
| Market Capitalization | ||
| Market Capitalization | ₹1.50B | ₹46.19B |
| Enterprise Value | ₹1.86B | ₹46.35B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.30 | 31.35 |
| Enterprise to EBITDA | 88.13 | 71.94 |
| Risk & Other Metrics | ||
| Beta | 0.20 | -0.37 |
| Book Value per Share (MRQ) | ₹68.67 | ₹22.80 |
Financial Statements Comparison: Auro Laboratories vs Gujarat Themis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AUROLAB | GUJTHEM |
|---|---|---|
| Revenue/Sales | ₹27.74M | ₹358.73M |
| Cost of Goods Sold | ₹9.01M | ₹79.97M |
| Gross Profit | ₹18.74M | ₹278.76M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-2.41M | ₹118.87M |
| EBITDA | ₹4.49M | ₹141.96M |
| Pre-Tax Income | ₹-1.06M | ₹121.20M |
| Income Tax | ₹0 | ₹30.58M |
| Net Income (Profit) | ₹-1.06M | ₹90.62M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AUROLAB | GUJTHEM |
|---|---|---|
| Cash & Equivalents | ₹3,000 | ₹116.94M |
| Total Current Assets | ₹215.14M | ₹519.73M |
| Total Current Liabilities | ₹216.42M | ₹205.60M |
| Long-Term Debt | ₹330.85M | ₹296.36M |
| Total Shareholders Equity | ₹429.68M | ₹2.48B |
| Retained Earnings | ₹359.52M | ₹2.37B |
| Property, Plant & Equipment | ₹16.55M | ₹411.30M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AUROLAB | GUJTHEM |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AUROLAB | GUJTHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 4,177 | 353,996 |
| Average Daily Volume (90 Day) | 6,853 | 202,276 |
| Shares Outstanding | 6.23M | 108.97M |
| Float Shares | 2.50M | 30.70M |
| % Held by Insiders | 0.60% | 0.71% |
| % Held by Institutions | 0.00% | 0.01% |
Dividend Analysis & Yield Comparison: Auro Laboratories vs Gujarat Themis
| Metric | AUROLAB | GUJTHEM |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.67 |
| Last 12-Month Dividend Yield | N/A | 0.17% |
| 3-Year Avg Annual Dividend | N/A | ₹0.22 |
| 3-Year Avg Dividend Yield | N/A | 0.17% |
| 3-Year Total Dividends | N/A | ₹0.67 |
| Ex-Dividend Date | N/A | Sep 04, 2025 |